بنر

جزئیات خبر

Created with Pixso. خونه Created with Pixso. اخبار Created with Pixso.

Tumor 56 Gene Testing for High-Volume Diagnostic Sourcing

Tumor 56 Gene Testing for High-Volume Diagnostic Sourcing

2026-09-05

Tumor 56 Gene Testing for High-Volume Diagnostic Sourcing

Overview

Diagnostic distributors need a gene panel that is affordable, repeatable, and simple to ship at volume. The fifty-six-gene tumor test covers twenty targeted and thirty-six chemotherapy genes in one compact assay. Compact scope keeps reagent cost and logistics light for high-throughput sourcing programs. Distributors prize predictable logistics as much as the clinical content itself.

How It Works

One extraction feeds a focused capture that targets only the fifty-six agreed loci. Standardized reagent kits let partner labs run the assay without bespoke optimization. Automated reporting templates produce consistent output across different sites. Quality metrics travel with every batch so procurement teams can audit performance. Lot-level controls mean every partner site produces comparable, audit-friendly output.

Indications

Networks serving community hospitals adopt the test as a steady baseline profiling offer. Budget-sensitive programs use it where a full broad panel is not justified clinically. Screening programs with fixed budgets adopt it as a standard first-line offer. Repeat surveillance testing benefits from the assay's predictable supply and price. Teaching hospitals use it to train staff on consistent reporting workflows.

Specimen Requirements & Reporting

Turnaround holds at about six working days to fit routine district workflows. Reports use a fixed field layout that integrates with distributor ordering systems. Result files export in formats that drop straight into existing case management. Couriers collect from multiple sites on a shared schedule to simplify district logistics.

Storage & Sourcing

Minimum order quantities are structured for monthly distributor commitments rather than one-offs. Reagent lots are allocated in advance so recurring demand never hits shortage. Specimens move in standardized cold packaging with tracking on every consignment. Forecast-based inventory prevents the stockouts that disrupt recurring test volumes.

FAQ

Q: What is the minimum order quantity for the 56-gene test? A: Commitments are structured as monthly distributor volumes rather than single-unit orders to keep pricing and supply stable.

Q: How stable is the supply for repeat testing? A: Reagent lots are pre-allocated, so recurring demand is fulfilled without the shortage risk of ad-hoc purchasing.

Q: What are the shipping requirements for specimens? A: Specimens travel in standardized cold packaging with tracking on every consignment to protect nucleic material.

Q: Do you offer white-label reporting for distributors? A: Automated templates support white-label output that drops into a distributor's own case-management system.

بنر
جزئیات خبر
Created with Pixso. خونه Created with Pixso. اخبار Created with Pixso.

Tumor 56 Gene Testing for High-Volume Diagnostic Sourcing

Tumor 56 Gene Testing for High-Volume Diagnostic Sourcing

Tumor 56 Gene Testing for High-Volume Diagnostic Sourcing

Overview

Diagnostic distributors need a gene panel that is affordable, repeatable, and simple to ship at volume. The fifty-six-gene tumor test covers twenty targeted and thirty-six chemotherapy genes in one compact assay. Compact scope keeps reagent cost and logistics light for high-throughput sourcing programs. Distributors prize predictable logistics as much as the clinical content itself.

How It Works

One extraction feeds a focused capture that targets only the fifty-six agreed loci. Standardized reagent kits let partner labs run the assay without bespoke optimization. Automated reporting templates produce consistent output across different sites. Quality metrics travel with every batch so procurement teams can audit performance. Lot-level controls mean every partner site produces comparable, audit-friendly output.

Indications

Networks serving community hospitals adopt the test as a steady baseline profiling offer. Budget-sensitive programs use it where a full broad panel is not justified clinically. Screening programs with fixed budgets adopt it as a standard first-line offer. Repeat surveillance testing benefits from the assay's predictable supply and price. Teaching hospitals use it to train staff on consistent reporting workflows.

Specimen Requirements & Reporting

Turnaround holds at about six working days to fit routine district workflows. Reports use a fixed field layout that integrates with distributor ordering systems. Result files export in formats that drop straight into existing case management. Couriers collect from multiple sites on a shared schedule to simplify district logistics.

Storage & Sourcing

Minimum order quantities are structured for monthly distributor commitments rather than one-offs. Reagent lots are allocated in advance so recurring demand never hits shortage. Specimens move in standardized cold packaging with tracking on every consignment. Forecast-based inventory prevents the stockouts that disrupt recurring test volumes.

FAQ

Q: What is the minimum order quantity for the 56-gene test? A: Commitments are structured as monthly distributor volumes rather than single-unit orders to keep pricing and supply stable.

Q: How stable is the supply for repeat testing? A: Reagent lots are pre-allocated, so recurring demand is fulfilled without the shortage risk of ad-hoc purchasing.

Q: What are the shipping requirements for specimens? A: Specimens travel in standardized cold packaging with tracking on every consignment to protect nucleic material.

Q: Do you offer white-label reporting for distributors? A: Automated templates support white-label output that drops into a distributor's own case-management system.